Latest news
Clearmind's CMND-100 trial reaches 160 mg with no serious adverse events - Stock TitanStock Titan · Thu, 30 Jul 2026 12:30:00 GMT24 Participants Complete Treatment in Clearmind's Alcohol Use Disorder Trial - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMTClearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial - The Manila TimesThe Manila Times · Tue, 28 Jul 2026 07:00:00 GMT